Close

Ratings by Jefferies (Eun Yang)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/24/2023 Paratek Pharmaceuticals PRTK Maintain Buy
(N/A)
 
 
  Details
1/11/2023 Albireo Pharma ALBO Downgrade Hold
(Buy)
43.85
(44.10)
0.57% Details
1/9/2023 CureVac CVAC Maintain Buy
(Hold)
 
 
  Details
12/16/2022 Astria Therapeutics ATXS Maintain Buy
(N/A)
 
 
  Details
12/8/2022 Lumos Pharma LUMO Downgrade Hold
(Buy)
4.83
(3.55)
-26.5% Details
11/14/2022 Lumos Pharma LUMO Downgrade Hold
(Buy)
8.91
(3.55)
-60.16% Details
11/14/2022 Prime Medicine PRME New Coverage Buy
(N/A)
20.57
(16.97)
-17.5% Details
11/9/2022 Taysha Gene Therapies TSHA Maintain Buy
(N/A)
 
 
  Details
11/8/2022 Rallybio Corp. RLYB Maintain Buy
(N/A)
 
 
  Details
9/22/2022 NuCana NCNA Maintain Buy
(N/A)
 
 
  Details
6/23/2022 United Therapeutics Corp. UTHR Maintain Buy
(N/A)
 
 
  Details
6/8/2022 Rigel Pharmaceuticals RIGL Downgrade Hold
(Buy)
1.76
(1.65)
-6.25% Details
5/24/2022 United Therapeutics Corp. UTHR Maintain Buy
(N/A)
 
 
  Details
4/1/2022 Taysha Gene Therapies TSHA Maintain Buy
(N/A)
 
 
  Details
3/23/2022 United Therapeutics Corp. UTHR Maintain Buy
(N/A)
 
 
  Details
3/3/2022 United Therapeutics Corp. UTHR Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Albireo Pharma ALBO Maintain Buy
(N/A)
 
 
  Details
2/25/2022 United Therapeutics Corp. UTHR Maintain Buy
(N/A)
 
 
  Details
1/24/2022 BridgeBio Pharma BBIO Maintain Buy
(N/A)
 
 
  Details
12/27/2021 BridgeBio Pharma BBIO Maintain Buy
(N/A)
 
 
  Details
11/2/2021 Pyxis Oncology Inc. PYXS New Coverage Buy
(N/A)
13.34
(1.56)
-88.31% Details
10/20/2021 Radius Health RDUS Maintain Hold
(N/A)
 
 
  Details
10/4/2021 BridgeBio Pharma BBIO Maintain Buy
(N/A)
 
 
  Details
9/29/2021 Astria Therapeutics ATXS New Coverage Buy
(N/A)
9.53
(13.49)
41.55% Details
8/23/2021 Rallybio Corp. RLYB New Coverage Buy
(N/A)
12.92
(6.90)
-46.59% Details
8/3/2021 Translate Bio TBIO Downgrade Hold
(Buy)
29.15
(1.82)
-93.76% Details
7/26/2021 Aerovate Therapeutics Inc AVTE New Coverage Buy
(N/A)
14.23
(23.69)
66.48% Details
7/15/2021 Generation Bio GBIO Maintain Buy
(N/A)
 
 
  Details
7/12/2021 Verve Therapeutics VERV New Coverage Buy
(N/A)
46.25
(21.77)
-52.93% Details
7/8/2021 Nabriva Therapeutics AG NBRV New Coverage Hold
(N/A)
1.27
(1.55)
22.05% Details
6/22/2021 Centessa Pharmaceuticals CNTA New Coverage Buy
(N/A)
24.91
(3.81)
-84.7% Details
6/9/2021 Cogent COGT New Coverage Buy
(N/A)
7.85
(14.36)
82.93% Details
5/11/2021 Taysha Gene Therapies TSHA New Coverage Buy
(N/A)
20.52
(1.54)
-92.5% Details
5/11/2021 Biomea Fusion Inc. BMEA New Coverage Buy
(N/A)
16.94
(9.69)
-42.8% Details
5/4/2021 Reneo Pharmaceuticals RPHM New Coverage Buy
(N/A)
14.40
(2.70)
-81.25% Details
4/8/2021 United Therapeutics Corp. UTHR Maintain Buy
(N/A)
 
 
  Details
3/26/2021 Albireo Pharma ALBO Maintain Buy
(N/A)
 
 
  Details
3/23/2021 BridgeBio Pharma BBIO Maintain Buy
(N/A)
 
 
  Details
3/5/2021 Five Prime Therapeutics FPRX Downgrade Hold
(Buy)
21.26
(38.00)
78.74% Details
3/2/2021 Paratek Pharmaceuticals PRTK New Coverage Buy
(N/A)
7.48
(2.07)
-72.33% Details
1/27/2021 BridgeBio Pharma BBIO Maintain Buy
(N/A)
 
 
  Details
10/12/2020 Dyne Therapeutics DYN New Coverage Buy
(N/A)
18.99
(14.61)
-23.06% Details
9/8/2020 Albireo Pharma ALBO Maintain Buy
(N/A)
 
 
  Details
9/8/2020 CureVac CVAC New Coverage Hold
(N/A)
56.92
(11.58)
-79.66% Details
8/14/2020 Lumos Pharma LUMO Maintain Buy
(N/A)
 
 
  Details
8/11/2020 Radius Health RDUS Maintain Hold
(N/A)
 
 
  Details
8/11/2020 Halozyme Therapeutics HALO Maintain Underperform
(N/A)
 
 
  Details
8/7/2020 Translate Bio TBIO Maintain Buy
(N/A)
 
 
  Details
8/5/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
7/7/2020 Generation Bio GBIO New Coverage Buy
(N/A)
19.56
(6.20)
-68.3% Details
5/18/2020 United Therapeutics Corp. UTHR Maintain Buy
(N/A)
 
 
  Details
5/18/2020 Deciphera DCPH Maintain Buy
(N/A)
 
 
  Details
5/11/2020 Halozyme Therapeutics HALO Maintain Underperform
(N/A)
 
 
  Details
4/16/2020 Lumos Pharma LUMO New Coverage Buy
(N/A)
9.21
(3.55)
-61.45% Details
3/10/2020 United Therapeutics Corp. UTHR Upgrade Buy
(Hold)
98.26
(258.71)
163.29% Details
3/10/2020 United Therapeutics Corp. UTHR Upgrade Buy
(Hold)
98.26
(258.71)
163.29% Details
10/16/2019 Alexion Pharmaceuticals ALXN Maintain Hold
(N/A)
 
 
  Details
9/30/2019 Deciphera DCPH New Coverage Buy
(N/A)
32.86
(17.04)
-48.14% Details
8/1/2019 United Therapeutics Corp. UTHR Upgrade Hold
(Underperform)
79.53
(258.71)
225.3% Details
7/23/2019 Ionis Pharmaceuticals IONS Maintain Underperform
(N/A)
 
 
  Details
7/22/2019 Translate Bio TBIO New Coverage Buy
(N/A)
9.60
(29.15)
203.65% Details
7/22/2019 BridgeBio Pharma BBIO New Coverage Buy
(N/A)
26.00
(8.95)
-65.58% Details
6/18/2019 Ra Pharma RARX Maintain Buy
(N/A)
 
 
  Details
6/17/2019 Blueprint Medicines BPMC Maintain Buy
(N/A)
 
 
  Details
6/17/2019 Array BioPharma ARRY Downgrade Hold
(Buy)
29.59
(21.25)
-28.19% Details
5/28/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
2/5/2019 Array BioPharma ARRY Maintain Buy
(N/A)
 
 
  Details
1/14/2019 La Jolla Pharma LJPC Upgrade Hold
(Underperform)
6.10
(6.22)
1.97% Details
12/20/2018 DBV Technologies S.A DBVT Downgrade Hold
(Buy)
14.69
(1.35)
-90.81% Details
10/30/2018 Array BioPharma ARRY Maintain Buy
(N/A)
 
 
  Details
9/12/2018 AMAG Pharmaceuticals AMAG Maintain Hold
(N/A)
 
 
  Details